finance.yahoo.com
Positivefinance.yahoo.com ·
lifevantage q3 earnings call highlights 021646573
WB_696_PUBLIC_SECTOR_MANAGEMENTWB_2048_COMPENSATION_CAREERS_AND_INCENTIVESWB_723_PUBLIC_ADMINISTRATIONWB_724_HUMAN_RESOURCES_FOR_PUBLIC_SECTOR
The full article is on the original publisher site. This page only shows the headline and a very short excerpt.
AI insight
AI-generatedLifeVantage, a direct-selling health/wellness company, reported a sharp revenue decline driven by weaker sales of its GLP-1 System and reduced active accounts. The company faces competitive pressure in the GLP-1 market, squeezing margins and forcing lower guidance. Impact is company-specific, not sector-wide, with no clear supply chain or commodity price channel.
Signals our AI researcher identified
Extracted by our AI model from this article and related public sources — not direct quotes from the publisher.
- Q3 net revenue declined 25.2% to $43.7 million.
- Adjusted EBITDA fell to $3.2 million (7.3% of revenue).
- LifeVantage appointed Terrence Moorehead as new CEO.
- Company ended quarter with $12.5 million cash, no debt.
- Announced 11% increase in quarterly dividend to $0.05.